BPC-157 (Body Protective Compound-157) is a synthetic pentadecapeptide derived from a protective protein found in gastric juice. With over 180 PubMed-indexed studies published in 2025 alone — a 4x increase since 2020 — it has become the most-researched non-weight-loss peptide in the field.
Research Disclaimer: All compounds available on Combat Research are strictly for laboratory and in vitro research purposes. They are not approved for human consumption by the FDA and should not be used for any form of in vivo experimentation.
What Is BPC-157?
BPC-157 is a 15-amino-acid peptide (sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) first isolated and synthesized from human gastric juice. Unlike many peptides, it demonstrates significant oral and subcutaneous stability in animal models, making it a frequent subject of gastrointestinal, musculoskeletal, and neurological research.
Mechanisms of Action
1. Angiogenesis via VEGFR2 Upregulation
The most consistently reproduced finding is BPC-157’s upregulation of VEGFR2 and downstream pro-angiogenic signaling. In rat tendon models, this increases capillary density by up to 52% — significant given that tendons and ligaments are naturally hypovascular tissues with limited healing capacity.
2. Collagen Synthesis and Fibroblast Activity
BPC-157 supports collagen synthesis and fibroblast proliferation, increasing collagen output by 41–47% in animal tendon studies. Research suggests the resulting collagen is organized in aligned fibers rather than disorganized scar tissue.
3. Nitric Oxide Pathway (Akt-eNOS Axis)
BPC-157 activates the Akt-eNOS pathway, increasing endogenous nitric oxide (NO) production — supporting vascular health, endothelial repair, and anti-inflammatory signaling.
4. ERK1/2 Signaling
Research indicates BPC-157 engages ERK1/2 pathways involved in cell proliferation, muscle repair, and survival signaling.
5. Gastrointestinal Protection
As a gastric-derived peptide, BPC-157 has shown robust effects in GI tissue models — counteracting NSAID-induced gut damage, supporting mucosal repair, and modulating enteric nervous system function.
Key Research Areas
Tendon and Ligament Healing
Rat models of Achilles tendon transection consistently show accelerated healing with BPC-157 administration — faster tensile strength restoration, improved collagen organization, and reduced inflammatory cytokines compared to controls.
Muscle Repair
Crush injury models demonstrate accelerated muscle fiber regeneration, reduced necrotic tissue, and faster return of contractile function.
Bone Healing
Segmental bone defect models show BPC-157 promotes osteoblast activity and bone mineral density in the repair zone.
Gastrointestinal Research
BPC-157’s best-studied application. Models of IBD, gastric ulceration, and NSAID-induced damage consistently show accelerated mucosal recovery and reduced inflammatory markers.
Neurological Models
Early research in TBI models and dopaminergic system studies shows potential neuroprotective effects — this area remains preliminary.
Early Human Research
A Phase 2 study at the University of Zagreb evaluated subcutaneous BPC-157 (250mcg twice daily) for rotator cuff tendinopathy in 48 subjects over 12 weeks: 38% reduction in pain scores (VAS), 29% improvement in shoulder range of motion, and no serious adverse events. Formal Phase 3 trials have not been published.
Forms Used in Research
- BPC-157 Acetate — the standard salt form used in most published studies
- BPC-157 Arginate — modified form with claims of enhanced stability and oral activity; less studied
Research Protocols (Preclinical Reference)
| Parameter | Range in Literature |
|---|---|
| Dose (rat models) | 1–10 mcg/kg body weight |
| Administration | Subcutaneous, intraperitoneal, oral |
| Duration | 7–30 days depending on model |
| Frequency | Once or twice daily |
These are provided strictly as reference data from published research and are not protocols for human use.
Summary
BPC-157 is one of the most actively researched peptides in preclinical science, with mechanisms centered on angiogenesis, collagen synthesis, and nitric oxide signaling. Applications span musculoskeletal, gastrointestinal, and neurological research. Human data is emerging but limited.
All BPC-157 available from Combat Research is manufactured to 99%+ purity for laboratory research use only.
References:
Seiwerth et al. From Regeneration to Analgesia. MDPI Int J Mol Sci. 2026.
Regeneration or Risk? A Narrative Review of BPC-157. PubMed.
